Bolt Biotherapeutics Statistics

Total Valuation

BOLT has a market cap or net worth of $19.14 million. The enterprise value is -$16.48 million.

Market Cap	19.14M
Enterprise Value	-16.48M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

BOLT has 38.27 million shares outstanding. The number of shares has increased by 1.02% in one year.

Current Share Class	38.27M
Shares Outstanding	38.27M
Shares Change (YoY)	+1.02%
Shares Change (QoQ)	+0.32%
Owned by Insiders (%)	3.98%
Owned by Institutions (%)	24.71%
Float	27.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.95
Forward PS	11.10
PB Ratio	0.27
P/TBV Ratio	0.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.16, with a Debt / Equity ratio of 0.25.

Current Ratio	3.16
Quick Ratio	3.00
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -64.99% and return on invested capital (ROIC) is -37.78%.

Return on Equity (ROE)	-64.99%
Return on Assets (ROA)	-31.76%
Return on Capital (ROIC)	-37.78%
Revenue Per Employee	$97,790
Profits Per Employee	-$650,850
Employee Count	100
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.93, so BOLT's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	-50.00%
50-Day Moving Average	0.61
200-Day Moving Average	0.80
Relative Strength Index (RSI)	31.01
Average Volume (20 Days)	184,053

Short Selling Information

The latest short interest is 120,910, so 0.32% of the outstanding shares have been sold short.

Short Interest	120,910
Short Previous Month	101,425
Short % of Shares Out	0.32%
Short % of Float	0.44%
Short Ratio (days to cover)	0.54

Income Statement

In the last 12 months, BOLT had revenue of $9.78 million and -$65.09 million in losses. Loss per share was -$1.71.

Revenue	9.78M
Gross Profit	-52.29M
Operating Income	-72.33M
Pretax Income	-63.03M
Net Income	-65.09M
EBITDA	-70.51M
EBIT	-72.33M
Loss Per Share	-$1.71

Full Income Statement

Balance Sheet

The company has $53.80 million in cash and $18.18 million in debt, giving a net cash position of $35.62 million or $0.93 per share.

Cash & Cash Equivalents	53.80M
Total Debt	18.18M
Net Cash	35.62M
Net Cash Per Share	$0.93
Equity (Book Value)	72.03M
Book Value Per Share	1.88
Working Capital	39.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$61.12 million and capital expenditures -$47,000, giving a free cash flow of -$61.17 million.

Operating Cash Flow	-61.12M
Capital Expenditures	-47,000
Free Cash Flow	-61.17M
FCF Per Share	-$1.60

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-739.68%
Pretax Margin	-665.56%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BOLT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.02%
Shareholder Yield	-1.02%
Earnings Yield	-340.11%
FCF Yield	-319.66%

Analyst Forecast

The average price target for BOLT is $1.25, which is 150.00% higher than the current price. The consensus rating is "Hold".

Price Target	$1.25
Price Target Difference	150.00%
Analyst Consensus	Hold
Analyst Count	5
Revenue Growth Forecast (5Y)	21.63%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BOLT has an Altman Z-Score of -6.35 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.35
Piotroski F-Score	3